Concepedia

C. Allott

CA

7

Publications

321

Citations

7

H-Index

1980

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

East Cheshire NHS Trust

C. Allott is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyNatural SciencesPhysiologyMedicinal ChemistryMolecular PharmacologyAsthma

Publications per year

1980–2000

7

Publications

7

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives

Andrew P. Thomas, C. Allott, Keith H. Gibson et al. · Journal of Medicinal Chemistry · 1992 · 91 citations · Full text

New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives

Robert H. Bradbury, C. Allott, Michael Robert Dennis et al. · Journal of Medicinal Chemistry · 1993 · 70 citations · Full text

Receptor Antagonists, Peptide Science, Pharmacotherapy +18

Hydrogen-bond recognition of cyclic dipeptides in water

C. Allott, Harry Adams, Christopher A. Hunter et al. · Chemical Communications · 1998 · 69 citations

Engineering, Biochemistry, Natural Sciences +12

New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives

Robert H. Bradbury, C. Allott, Michael Robert Dennis et al. · Journal of Medicinal Chemistry · 1992 · 54 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +15

A MODEL OF IRRITANT‐INDUCED BRONCHOCONSTRICTION IN THE SPONTANEOUSLY BREATHING GUINEA‐PIG

C. Allott, David P. Evans, Philip Marshall · British Journal of Pharmacology · 1980 · 16 citations · Full text

Asthma, Inflammatory Lung Disease, Allergy +14

Rows per page

1–5 of 7